Nathan Brown > Akin > Washington DC, United States > Lawyer Profile

Akin
Robert S. Strauss Tower
2001 K Street, N.W.
Washington, DC 20006-1037
DISTRICT OF COLUMBIA
United States
Nathan Brown photo

Work Department

Partner; Health

Position

Drawing upon his 20+ years of diverse health care industry and governmental experience, Nate provides clients with strategic, practical advice on cutting-edge regulatory, compliance and policy matters. He has worked extensively in the FDA regulatory field and on coverage and reimbursement matters, allowing him to make connections across disciplines and take a multifaceted, creative approach to advising clients. Nate is a leading authority in the regulation of medical devices, particularly medical software, digital health and diagnostics. He has served in prominent roles at FDA and on the Senate HELP Committee. He is outside counsel to a broad cross section of the most innovative and influential entities in medical technologies, including the most well-established device and diagnostics companies, leading academic medical centers, visionary start-ups, digital technology companies newly entering health care and the leading trade association for the device industry. He has played an active role on behalf of clients in shaping many recent legislative reforms for medical technologies.

To learn more about Nate, please visit his full profile: https://www.akingump.com/en/lawyers-advisors/nathan-a-brown.html

Career

Leads the firm’s FDA Practice; Associate Chief Counsel, Office of Chief Counsel, FDA; Senior Counsel, Office of the Associate Commissioner for Regulatory Affairs, FDA; Counsel, Senate HELP Committee.

Memberships

Member, Food and Drug Law Journal Editorial Advisory Board. FDA Alumni Association.

Lawyer Rankings

United States > Healthcare > Life sciences

Akin brings an in-depth understanding of FDA regulatory regimes to bear for clients in the pharmaceutical sector, with particular expertise in rules governing the burgeoning area of digital health, where the practice assists with the integration of AI into diagnostics and treatment planning systems. Practice head Nathan Brown brings ‘an impressive understanding of historical and current FDA enforcement and oversight approaches’ to the table, representing drug, medical devices and diagnostics developers seeking FDA clearance for new products and advising on FDA-compliant marketing strategies; he is based in Washington DC. In New York, Craig Bleifer handles issues ranging from clinical trials to product labelling, with further expertise on the FCA.